TATA Health International Holdings Ltd. stock analysis
Want to see HK:1255 full AI Analyst Report?
TATA Health International Holdings Ltd. (1255) Stock Price & Analysis
1255 Stock Chart & Stats
- Day’s Range
- HKD 1.58 - HKD 1.58
- 52-Week Range
- HKD 0.30 - HKD 3.79
- Previous Close
- HKD 1.71
- Volume
- N/A
- Average Volume (3M)
- 3,267
- Market Cap
- HKD 383.70M
- Enterprise Value
- HKD 871.12M
- Total Cash (Recent Filing)
- HKD 10.43M
- Total Debt (Recent Filing)
- HKD 32.63M
- Price to Earnings (P/E)
- ―
- Beta
- 0.27
- Next Earnings
- Apr 01, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Mar 18, 2015
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue Recovery
The reported 11.34% revenue growth and 2025 rebound show that the business retained some capacity to recover sales after the prior contraction. If sustained, improving top-line scale could support operating leverage and provide a more durable base for rebuilding profitability, although the broader record remains uneven.
Strong Gross Margin
An approximately 80% gross margin indicates that the company retains substantial gross profit after direct costs in the latest year. This provides a potentially valuable buffer for funding overhead and investment, though it has not yet translated into consistently positive operating performance.
Debt Reduction
Debt reduction from the 2020 peak represents some progress in lowering financial obligations and may reduce pressure on future cash flows. This improvement could support greater financial resilience over time, although the benefit is constrained by negative equity and weak recent operating profitability.
Bears Say
Negative Equity
Negative shareholders’ equity signals a very thin capital base and materially limits financial flexibility. It also distorts leverage measures, making the company more exposed to funding pressure and leaving less balance-sheet capacity to absorb operating setbacks or support future investment.
Cash Burn
Negative operating and free cash flow in the latest year indicates that reported activities were not converting into internally generated cash. Persistent cash burn can increase reliance on external funding, restrict investment capacity, and make the recovery more vulnerable if weak cash conversion continues.
Unstable Profitability
Volatile revenue and recurring negative operating margins point to an earnings profile that is not yet dependable. Although net income returned to profit in 2025, the history of large losses and weak core operating results suggests that the improvement may not represent a durable earnings base.
TATA Health International Holdings Ltd. News
TATA Health Aims to Clear Audit Disclaimer by 2027 After Subsidiary Disposals and Loan Impairments
TATA Health International Holdings Ltd. ( ($HK:1255) ) has shared an announcement. TATA Health International Holdings has issued a supplemental announcement clarifying management and audit committee views on the disclaimer
1255 FAQ
What was TATA Health International Holdings Ltd.’s price range in the past 12 months?
What is TATA Health International Holdings Ltd.’s market cap?
When is TATA Health International Holdings Ltd.’s upcoming earnings report date?
How were TATA Health International Holdings Ltd.’s earnings last quarter?
Is TATA Health International Holdings Ltd. overvalued?
Does TATA Health International Holdings Ltd. pay dividends?
What is TATA Health International Holdings Ltd.’s EPS estimate?
How many shares outstanding does TATA Health International Holdings Ltd. have?
What happened to TATA Health International Holdings Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of TATA Health International Holdings Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
TATA Health International Holdings Ltd.
TATA Health International Holdings Limited functions as an investment holding company with diverse business interests, including the sale of footwear and healthcare goods, in addition to offering financial and online medical services. Its operations are structured into distinct segments: Footwear Products Trading, Healthcare Products Trading, Financial Services, and Online Medical Services. The company engages in both wholesale and retail distribution of footwear, featuring prominent brands like Clarks and Josef Seibel. By December 31, 2021, its retail footprint included 29 stores in Hong Kong and one in Macau. Furthermore, its financial services division provides expertise in securities advisory, investment management, and corporate finance consultancy. The company maintains a geographical presence across Hong Kong, Australia, Macau, and Mainland China. Founded in 1974 and headquartered in Kwai Chung, Hong Kong, the firm rebranded from S. Culture International Holdings Limited to its current name in November 2020.
- Sector
- Consumercyclical
- Industry
- Apparel - Footwear & Accessories
- CEO
- Ming Qi Zhang
- Employees
- 107
- Website
- www.s-culture.com
- Address
- HK
TATA Health International Holdings Ltd. (1255) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 1 | 15 |
| Technical Analysis | 6 | 1 | 3 |
| Moving Averages | 0 | 0 | 12 |








